Evidence map›Paper›PMID 41006205›Full record

ArticleNature communications2025

A conserved long-range RNA interaction in SARS-CoV-2 recruits ADAR1 to enhance virus proliferation.

Siwy Ling Yang, Louis DeFalco, Sainan Wang, Yi Hao Wong, Jian Han, Chee Keng Mok, Kiat Yee Tan, Su Ying Lim, Zhiya Zhao, Yu Zhang and 8 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Siwy Ling Yang *Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, 138672, Singapore. yangsl@a-star.edu.sg.ORCID http://orcid.org/0000-0001-9560-9633
Louis DeFalco *Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore, 138671, Singapore.ORCID http://orcid.org/0000-0003-1874-1838
Sainan Wang *Institute of Bioengineering, University of Tartu, Tartu, Estonia.ORCID http://orcid.org/0000-0002-7046-4965
Yi Hao WongNUSMed Biosafety Level 3 Core Facility, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.ORCID http://orcid.org/0000-0001-6704-9130
Jian HanGenome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, 138672, Singapore.
Chee Keng MokInfectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore, 138648, Singapore.ORCID http://orcid.org/0000-0002-9239-0223
Kiat Yee TanGenome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, 138672, Singapore.
Su Ying LimGenome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, 138672, Singapore.
Zhiya ZhaoGenome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, 138672, Singapore.
Yu ZhangGenome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, 138672, Singapore.ORCID http://orcid.org/0000-0003-1567-289X
Jovi Jian An LimGenome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, 138672, Singapore.
Joy S XiangDivision of Biomedical Sciences, University of California, Riverside, California, USA.ORCID http://orcid.org/0000-0002-6400-1876
Radoslaw SobotaInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.ORCID http://orcid.org/0000-0002-2455-2526
Lin-Fa WangProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.ORCID http://orcid.org/0000-0003-2752-0535
Justin Jang Hann ChuNUSMed Biosafety Level 3 Core Facility, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.ORCID http://orcid.org/0000-0002-1673-6819
Andres MeritsInstitute of Bioengineering, University of Tartu, Tartu, Estonia. andres.merits@ut.ee.ORCID http://orcid.org/0000-0001-8193-0071
Roland G HuberBioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore, 138671, Singapore. rghuber@bii.a-star.edu.sg.ORCID http://orcid.org/0000-0001-5093-5988
Yue WanGenome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, 138672, Singapore. WAN_Yue@a-star.edu.sg.ORCID http://orcid.org/0000-0002-2433-9637

Funding

National Research Foundation Singapore (National Research Foundation-Prime Minister's office, Republic of Singapore) CRP27-2021-003
6 · The paper itself

Abstract

Long-range RNA-RNA pairing impacts the genome structure and function of SARS-CoV-2 variants. To understand the structure and function relationships of different SARS-CoV-2 variants that have emerged during the COVID-19 pandemic, we perform high-throughput structure probing and modelling of the genomic structures of the wildtype (WT), Alpha, Beta, Delta and Omicron variants of SARS-CoV-2. We observe that genomes of SARS-CoV-2 variants are generally structurally conserved, and that single-nucleotide variations and interactions with RNA binding proteins can impact RNA structures across the viruses. Importantly, using proximity ligation sequencing, we identify many conserved ultra-long-range RNA-RNA interactions, including one that spans more than 17 kb in both the WT virus and the Omicron variant. We show that mutations that disrupt this 17 kb long-range interaction reduce viral fitness at later stages of its infection cycle, while compensatory mutations partially restore virus fitness. Additionally, we show that this ultra-long-range RNA-RNA interaction structure binds directly to ADAR1 to alter the RNA editing levels on the viral genome. These studies deepen our understanding of RNA structures in the SARS-CoV-2 genome and their ability to interact with host factors to facilitate virus infectivity.

Indexed as

Adenosine DeaminaseCOVID-19RNA-Binding ProteinsRNA, ViralSARS-CoV-2Genome, ViralHEK293 CellsHumansMutationNucleic Acid ConformationVirus ReplicationADAR protein, humanAdenosine DeaminaseRNA-Binding ProteinsRNA, Viral

Identifiers

PMID41006205
PMCPMC12475128

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.